Oncology Institute (TOI) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to -$0.14.
- Oncology Institute's EPS (Weighted Average and Diluted) rose 2222.22% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.14, marking a year-over-year increase of 2222.22%. This contributed to the annual value of -$0.71 for FY2024, which is 2282.61% up from last year.
- As of Q3 2025, Oncology Institute's EPS (Weighted Average and Diluted) stood at -$0.14, which was up 2222.22% from -$0.15 recorded in Q2 2025.
- In the past 5 years, Oncology Institute's EPS (Weighted Average and Diluted) registered a high of $0.21 during Q1 2022, and its lowest value of -$0.33 during Q1 2023.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.13, with a median of -$0.17 in 2022.
- Per our database at Business Quant, Oncology Institute's EPS (Weighted Average and Diluted) tumbled by 22169136125.0% in 2021 and then surged by 115000.0% in 2022.
- Quarter analysis of 5 years shows Oncology Institute's EPS (Weighted Average and Diluted) stood at -$0.15 in 2021, then decreased by 20.0% to -$0.18 in 2022, then dropped by 16.67% to -$0.21 in 2023, then rose by 28.57% to -$0.15 in 2024, then grew by 6.67% to -$0.14 in 2025.
- Its last three reported values are -$0.14 in Q3 2025, -$0.15 for Q2 2025, and -$0.21 during Q1 2025.